LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $194.05M |
| Net Income (Most Recent Fiscal Year) | $14.35M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 0.80 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 20.64 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -10.51% |
| Net Margin (Trailing 12 Months) | 0.10% |
| Return on Equity (Trailing 12 Months) | -168.23% |
| Return on Assets (Trailing 12 Months) | -31.27% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.90 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.84 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 7.76 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.17 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.16 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.30 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.05 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 48.20M |
| Free Float | 39.90M |
| Market Capitalization | $163.88M |
| Average Volume (Last 20 Days) | 1.13M |
| Beta (Past 60 Months) | 2.02 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 17.22% |
| Percentage Held By Institutions (Latest 13F Reports) | 35.52% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |